The effect of topical semisolid formulation of metformin on severity and number of skin lesions in acne patients.
- Conditions
- Acne vulgaris.Acne vulgaris
- Registration Number
- IRCT2017013132319N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Patients with mild to moderate acne, defined as a score of 1 to 30 on the global acne grading system (GAGS) scale, who did not get any treatment before, or were not satisfied with their previous acne therapies, will be participated in the study after giving written informed consent. Exclusion criteria: Patients will be excluded if they are diabetic or have an uncontrolled systemic disease; have received topical anti acne therapy two months before or during the study or any systemic therapy, 30 days before or during the study; were known to be allergic or sensitive to any of the study medications or their components; have a skin disease that might interfere with the diagnosis or evaluation of their skin lesions; pregnant women and lactating ones.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Skin lesions. Timepoint: 0 , 4 , 8 weeks. Method of measurement: Observation.
- Secondary Outcome Measures
Name Time Method Patients satisfaction. Timepoint: 0,4,8 weeks. Method of measurement: determined by a 10 point scale ranging.